Compounds for the treatment of Hepatitis C

US7538102B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Kap-Sun Yeung · Madison, US
• John A. Bender · Middletown, US
• Robert G. Gentles · Killingworth, US
• Zhong Yang · Middletown, US
• Min Ding · Dobbs Ferry, US
• Yong Tu · Cheshire, US
• Piyasena Hewawasam · Middletown, US
• Ying Han · Cheshire, US
• John F. Kadow · Wallingford, US

Key dates

• Filing date: Mar 11, 2008
• Grant date: May 26, 2009
• Expiry date: Mar 11, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D519/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention encompasses compounds of Formula I, pharmaceutically acceptable salts thereof, compositions, and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.